Table 3.
Laboratory findings in neurological manifestation in COVID-19
Author | Manifestation | Laboratory finding | Reference |
---|---|---|---|
Avula et al. | Stroke | - Lymphopenia | [46, 48] |
- Elevated C-reactive [26 mg/dl (0.04 mg/dl)] | |||
- Elevated D-dimer [mean 8704 ng/ml (< 880 ng/ml) | |||
- Elevated lactate dehydrogenase (712 U/L) | |||
Oxley et al. | - D-dimer [5972 ng/ml (0–500 ng/ml)] | ||
Moringuchi et al. | Meningoencephalitis | - Elevated neutrophil | [45] |
- Increased C-reactive protein | |||
Guitierrez-Ortiz et al. | Guillain-Barré syndrome | - Lymphopenia (1000 cells/μl) | [50, 51, 54] |
- Leucopenia (3100/cells/μl) | |||
- Elevated C-reactive protein (2.8 mg/dl) | |||
- Positive GD1b-IgG ganglioside antibody | |||
Virani et al. | - Lymphopenia and thrombocytopenia | ||
Zhao et al. | - Lymphocytopenia [0.52 × 109/L (1.1–3.2 × 109/L)] | ||
- Thrombocytopenia [113 × 109/L (125–3000 × 109/L)] |